RPM Partnerships

Growth in the Remote Patient Monitoring (RPM) market is driven by healthcare's overall need to decentralise as well as the recent pandemic. There are now many existing RPM providers with more coming. PBM is looking for partnerships where ProCVT can be used to enhance existing product offerings.

For companies which deliver a broader range of virtual care with remote consultancy and a range of peripheral devices (eg. blood pressure/glucose, weight), the addition of the data from ProCVT would effortlessly provide a much fuller picture of their customer’s health. This would be particularly relevant for customers at risk of/concerned about cardiac issues as well as for general health and wellbeing.

RPM companies which monitor or diagnose specific conditions, such as Atrial Fibrillation, provide adhesive patches for limited duration analysis. Ongoing monitoring of the condition or effectiveness of any treatment is currently by consultation. ProCVT can be offered as a follow-on service to effortlessly monitor an ongoing condition and effectiveness of treatment, without any wearables.